Asthma Treatment Market to Grow at 4.5% CAGR, Reaching $28.27 Billion by 2029

Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.

Asthma Treatment Market Outlook: How is the Market Expected to Grow by 2025?
Over recent years, the size of the market for asthma treatments has seen a consistent increase. It is set to expand from $22.69 billion in 2024 to $23.75 billion in 2025, at a compound annual growth rate (CAGR) of 4.7%. Factors contributing to this growth during the historical period include a rise in urbanization and pollution levels, heightened usage of inhalers and nebulizers, improved access to healthcare in developing economies, increased awareness and detection rates, and a surge in allergen exposure.

Asthma Treatment Market Forecast: What Size Will It Reach By 2029?
Expectations for consistent growth in the asthma treatment market over the next several years are strong, with projections indicating that the market could reach $28.27 billion in 2029, demonstrating a compound annual growth rate (CAGR) of 4.5%. This projected increase during the forecasted period can be linked to a rising emphasis on tailored asthma treatments, an uptake in the use of biologics and monoclonal antibodies, further investment into research and development for respiratory medications, the increasing utilization of telehealth and digital tools for asthma management, as well as growing government initiatives addressing chronic respiratory care. Upcoming trends during this period include advancement in biologic therapies aimed at severe asthma, the introduction of advanced digital inhalers equipped with tracking features, the progression of personalized medicine strategies, advancements in drug-delivery technology, and the further development of AI-based platforms designed for the management of asthma.

Explore The Complete Report Now:
https://www.thebusinessresearchcompany.com/report/asthma-treatment-global-market-report

Which Key Market Drivers Will Shape Asthma Treatment Industry Trends in 2025-2029?
The increasing incidence of conditions that affect the lungs and breathing, such as chronic obstructive pulmonary disease (COPD), bronchitis, and notably, asthma, is poised to fuel the expansion of the asthma treatment market. A significant cause of these increasing respiratory issues is air pollution, which exacerbates conditions like asthma due to the irritation and inflammation of airways from particulates and nitrogen oxides, intensifying breathing challenges. This surge in respiratory illnesses heightens the demand for asthma treatments, which include medication, inhalers, and lifestyle modifications to manage airway inflammation and symptoms. The National Library of Medicine, based in the US, predicted in December 2023 that by 2050, COPD cases in low- and middle-income countries will exceed more than twice those in high-income nations. They projected a significant 59% increase in sub-Saharan Africa, anticipating it to be the global leader in COPD prevalence and cases by 2040. Consequently, this increasing trend in respiratory diseases is powering the growth of the asthma treatment market.

Get Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25703&type=smp

What Are the High-Growth Segments in the Asthma Treatment Market?
The asthma treatment market covered in this report is segmented -

1) By Treatment: Long-Term Control Medications, Quick-Relief Medications
2) By Device Type: Inhalers, Dry Powder, Metered Dose, Soft Mist Nebulizers
3) By Drug Class: Short-Acting Beta-Agonists (SABA), Long-Acting Beta-Agonists (LABA), Inhaled Corticosteroids (ICS), Leukotriene Modifiers, Immunomodulators, Combination Drugs, Other Drug Class
4) By Route Of Administration: Oral, Inhaled, Intravenous, Subcutaneous
5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

Subsegments:
1) By Long-Term Control Medications: Inhaled Corticosteroids (ICS), Long-Acting Beta-Agonists (LABA), Leukotriene Receptor Antagonists (LTRA), Long-Acting Muscarinic Antagonists (LAMA), Methylxanthines, Biologics
2) By Quick-Relief Medications: Short-Acting Beta-Agonists (SABA), Systemic Corticosteroids, Anticholinergics

Which Global Trends Are Driving Asthma Treatment Market Expansion?
Leading organizations in the asthma treatment market are prioritizing the creation of novel therapeutic solutions, like anti-inflammatory rescue inhalers, to facilitate quick symptom relief and tackle inherent airway inflammation in individuals with asthma. These inhalers offer a dual function - they provide immediate relief from asthma symptoms while simultaneously curbing airway inflammation during an asthma crisis. For instance, AstraZeneca, a leading biopharmaceutical company based in the UK, introduced AIRSUPRA (albuterol/budesonide), a ground-breaking inhaler therapy for managing asthma, in January 2024. This is the first of its kind to receive FDA approval, combining a fixed dose of albuterol, a short-acting beta2-agonist (SABA), and budesonide, an inhaled corticosteroid (ICS). It's designed as a rescue medication for asthmatics, providing quick bronchodilation and addressing airway inflammation during an asthma flare-up. This inhaler, which allows for a single inhalation, manages both symptoms and underlying inflammation. It's prescribed for asthmatic patients aged 18 years and older, supporting improved overall management of the condition and reducing dependency on separate controlling medications.

Customize Your Insights And Get The Full Report Here:
https://www.thebusinessresearchcompany.com/customise?id=25703&type=smp

Who Are the Fastest-Growing Companies in the Asthma Treatment Industry?
Major companies operating in the asthma treatment market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca PLC, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Amgen Inc., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Limited, Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Genentech Inc., Sumitomo Pharma Co Ltd., Chiesi Farmaceutici S.p.A., Cipla Limited.

What Is the Regional Outlook for the Asthma Treatment Market by 2029?
North America was the largest region in the asthma treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the asthma treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.